Tiago Biachi (@biachitiago) 's Twitter Profile
Tiago Biachi

@biachitiago

GI Medical Oncologist, Associate Member Moffitt Cancer Center, Associate Professor USF, views are my own

ID: 1110591495835447298

linkhttp://www.moffitt.org calendar_today26-03-2019 17:17:01

632 Tweet

2,2K Followers

1,1K Following

Dr. Patrick Hwu (@patrickhwumd) 's Twitter Profile Photo

Excited to be joined by biotech executives, entrepreneurs, investors and researchers today at #MoffittBoB to discuss the latest advances in cancer care. A big thank you to Secretary J. Alex Kelly Alex Kelly for kicking off the event at our leadership breakfast.

Excited to be joined by biotech executives, entrepreneurs, investors and researchers today at #MoffittBoB to discuss the latest advances in cancer care. A big thank you to <a href="/FLSecofCommerce/">Secretary J. Alex Kelly</a> Alex Kelly for kicking off the event at our leadership breakfast.
Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Make strides against pancreatic cancer by joining this year's PurpleStride walk. For more visit purplestride.org/tampa. Full interview with Dr Malafa, our top-notch pancreas surgeon at Moffitt Cancer Center here: wtsp.com/video/features…

Make strides against pancreatic cancer by joining this year's PurpleStride walk. For more visit purplestride.org/tampa.

Full interview with Dr Malafa, our top-notch pancreas surgeon at <a href="/MoffittNews/">Moffitt Cancer Center</a>  here: 

wtsp.com/video/features…
Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Working in a paper about adjuvant aspirin in #colorectal cancer made me think about this curve. Also, curious to see results from ATOMIC trial with adjuvant atezo at #asco2025 and how long the implementation will take (compared to aspirin in PIK3CA mutant)

Working in a paper about adjuvant aspirin in #colorectal cancer made me think about this curve.

Also, curious to see results from ATOMIC trial with adjuvant atezo at #asco2025 and how long the implementation will take (compared to aspirin in PIK3CA mutant)
Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Post hoc analysis from FIRE-4 (1L RAS/BRAF wt) found 13% were RAS mutant and 7% BRAFV600E mutant at baseline #liquidbiopsy ascopubs.org/doi/abs/10.120… Even more important now that more targeted therapies are coming to 1L in #colorectalcancer

Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Honored to be recognized by this team of true heroes. While they keep our city safe, together we can contribute to the prevention and cure of cancer. #firefightersTampa IAFF Tampa Firefighters Local 754 Moffitt Cancer Center

Honored to be recognized by this team of true heroes. While they keep our city safe, together we can contribute to the prevention and cure of cancer.

#firefightersTampa 
<a href="/TFF754/">IAFF Tampa Firefighters Local 754</a> 
<a href="/MoffittNews/">Moffitt Cancer Center</a>
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Live from #ASCO25: Yelena Janjigian, MD, (Yelena Y. Janjigian MD Memorial Sloan Kettering Cancer Center) shares results from MATTERHORN, showing support for global adoption of perioperative durvalumab with FLOT as a new standard for patients with localized gastric and gastroesophageal adenocarcinoma.

Live from #ASCO25: Yelena Janjigian, MD, (<a href="/YJanjigianMD/">Yelena Y. Janjigian MD</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a>) shares results from MATTERHORN, showing support for global adoption of perioperative durvalumab with FLOT as a new standard for patients with localized gastric and gastroesophageal adenocarcinoma.
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

At #ASCO25, Tiago Biachi, MD, PhD (Tiago Biachi), caught up with Richard Kim, MD, to discuss top GI cancer studies and what they mean for the future of patient care. #MoffittASCO25 ASCO

Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Piece recorded for BayNews9 highlighting the importance of colorectal cancer screening and genetic counseling. Moffitt Cancer Center #JuneRogersFoundation #FightLikeJune baynews9.com/fl/tampa/sport…

Tiago Biachi (@biachitiago) 's Twitter Profile Photo

FY2026 will start in a great way! Elected as a member-at-large on the Medical Staff Committee and tenure going into effect at Moffitt. Always grateful for the opportunities that have come my way! 🙏🏼🙏🏼 Moffitt Cancer Center

Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Honored to be named co-Chair for Oncology Research Information Exchange Network (ORIEN) - GI group! Looking forward to seeing great ideas coming from this truly collaborative group! Moffitt Cancer Center

Tiago Biachi (@biachitiago) 's Twitter Profile Photo

FLASCO Leadership Strategy Session this weekend. Great time to discuss advocacy, cancer care delivery, partnerships, research and to celebrate 7000 members at FLASCO

FLASCO Leadership Strategy Session this weekend. 
Great time to discuss advocacy, cancer care delivery, partnerships, research and to celebrate 7000 members at <a href="/FLASCO_ORG/">FLASCO</a>
Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Back to X to share some good science in colon and liver cancer… Important paper published by Yu Xu et al. 5% of MMRp CRC were MSI-H, most with MMR genes mutant (and protein retained) or with MSH3 mutation. We might be missing CRC pts as candidates to IO and possible curable

Back to X  to share some good science in  colon and liver cancer…

Important paper published by Yu Xu et al.

5% of MMRp CRC were MSI-H, most with MMR genes mutant (and protein retained) or with MSH3 mutation.

We might be missing CRC pts as candidates to IO and possible curable
Tiago Biachi (@biachitiago) 's Twitter Profile Photo

Great opportunity to discuss all the progress that we had last few years in rectal cancer.. join Moffitt Cancer Center team in this discussion! NCCN Tumor Board – Live Webinar Wednesday, September 17 @ 11 AM EDT Exploring Omission of Radiation Therapy in the Management of Rectal Cancer

Great opportunity to discuss all the progress that we had last few years in rectal cancer.. join <a href="/MoffittNews/">Moffitt Cancer Center</a> team in this discussion! 

NCCN Tumor Board – Live Webinar 
Wednesday, September 17 @ 11 AM EDT
Exploring Omission of Radiation Therapy in the Management of Rectal Cancer